| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |